These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23806972)

  • 1. Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles.
    Liu Q; Li RT; Qian HQ; Wei J; Xie L; Shen J; Yang M; Qian XP; Yu LX; Jiang XQ; Liu BR
    Biomaterials; 2013 Sep; 34(29):7191-203. PubMed ID: 23806972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Codelivery of salinomycin and docetaxel using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles to target both gastric cancer cells and cancer stem cells.
    Li L; Cui D; Ye L; Li Y; Zhu L; Yang L; Bai B; Nie Z; Gao J; Cao Y
    Anticancer Drugs; 2017 Oct; 28(9):989-1001. PubMed ID: 28692437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer.
    Cui FB; Li RT; Liu Q; Wu PY; Hu WJ; Yue GF; Ding H; Yu LX; Qian XP; Liu BR
    Cancer Lett; 2014 Apr; 346(1):53-62. PubMed ID: 24333735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined delivery of salinomycin and docetaxel by dual-targeting gelatinase nanoparticles effectively inhibits cervical cancer cells and cancer stem cells.
    Wang Q; Yen YT; Xie C; Liu F; Liu Q; Wei J; Yu L; Wang L; Meng F; Li R; Liu B
    Drug Deliv; 2021 Dec; 28(1):510-519. PubMed ID: 33657950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
    Hu N; Yin JF; Ji Z; Hong Y; Wu P; Bian B; Song Z; Li R; Liu Q; Wu F
    Cell Physiol Biochem; 2017; 44(6):2158-2173. PubMed ID: 29241186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of radiotherapy efficacy by miR-200c-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer cells.
    Cui FB; Liu Q; Li RT; Shen J; Wu PY; Yu LX; Hu WJ; Wu FL; Jiang CP; Yue GF; Qian XP; Jiang XQ; Liu BR
    Int J Nanomedicine; 2014; 9():2345-58. PubMed ID: 24872697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
    Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
    Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanovesicle-mediated systemic delivery of microRNA-34a for CD44 overexpressing gastric cancer stem cell therapy.
    Jang E; Kim E; Son HY; Lim EK; Lee H; Choi Y; Park K; Han S; Suh JS; Huh YM; Haam S
    Biomaterials; 2016 Oct; 105():12-24. PubMed ID: 27497057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
    Tang H; Deng M; Tang Y; Xie X; Guo J; Kong Y; Ye F; Su Q; Xie X
    Clin Cancer Res; 2013 Oct; 19(20):5602-12. PubMed ID: 23995857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell.
    Liu J; Meng T; Yuan M; Wen L; Cheng B; Liu N; Huang X; Hong Y; Yuan H; Hu F
    Int J Nanomedicine; 2016; 11():6713-6725. PubMed ID: 28003747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells.
    Wang Q; Liu F; Wang L; Xie C; Wu P; Du S; Zhou S; Sun Z; Liu Q; Yu L; Liu B; Li R
    Int J Nanomedicine; 2020; 15():1283-1295. PubMed ID: 32161458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth.
    Gao H; Yang Z; Zhang S; Cao S; Pang Z; Yang X; Jiang X
    J Control Release; 2013 Dec; 172(3):921-8. PubMed ID: 24120853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gelatinase-stimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly(ethylene glycol)-poly(ɛ-caprolactone) nanoparticles.
    Liu Q; Li RT; Qian HQ; Yang M; Zhu ZS; Wu W; Qian XP; Yu LX; Jiang XQ; Liu BR
    Int J Nanomedicine; 2012; 7():281-95. PubMed ID: 22287839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles.
    Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B
    Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gab2 promotes cancer stem cell like properties and metastatic growth of ovarian cancer via downregulation of miR-200c.
    Fang Z; Li T; Chen W; Wu D; Qin Y; Liu M; Wu G; He L; Li H; Gu H
    Exp Cell Res; 2019 Sep; 382(1):111462. PubMed ID: 31194976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
    Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
    Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergistic antitumor activity of resveratrol and miR-200c in human lung cancer.
    Bai T; Dong DS; Pei L
    Oncol Rep; 2014 May; 31(5):2293-7. PubMed ID: 24647918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells.
    D'Almeida O; Mothar O; Bondzie EA; Lieumo Y; Tagne L; Gupta S; Volkert T; Levine S; Tagne JB
    BMC Cancer; 2019 Feb; 19(1):136. PubMed ID: 30744585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
    Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
    Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
    Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
    J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.